Open access
Optimized plasma p‐tau217 and p‐tau217/Aβ42 cutoffs enhance detection of pre‐clinical Alzheimer's disease across diverse participants
Y. Piura
P. Aduen
Leah Schecter
Manoj K. Jain
A. Algeciras-Schimnich
D. Figdore
Joshua A Bornhorst
R. C. Petersen
C. Jack
N. Graff-Radford
Christian Lachner
Gregory S. Day
Medicine
Abstract
Plasma p‐tau217 and p‐tau217/Aβ42 reliably identify non‐Hispanic White individuals with symptomatic and pre‐clinical AD. However, performance across ethnoracially diverse groups remains unknown.